Importantly, miR-195 and BIRC5 expression are significantly associated with lung adenocarcinoma patient survival, but not squamous cell carcinoma patient survival, suggesting that the miR-195/survivin axis might be a more important prognostic marker and therapeutic target in lung adenocarcinoma. Here, BIRC5 is linked to lung adenocarcinoma.